Tari, Akira <br/><br/>
Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Aug 2018 
 - 1461-1468 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1440-1746 
<br/><br/><label>Standard No.: </label>10.1111/jgh.14100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asian People<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Intestinal Neoplasms--pathology<br/>Lymphoma, Follicular--pathology<br/>Male<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Prospective Studies<br/>Rituximab--administration & dosage<br/>Treatment Outcome<br/>Tumor Burden<br/>Vincristine--administration & dosage<br/>Watchful Waiting